文献速递急性肾损伤慢性肾脏病肾血管病与高血压

凋亡小体在肾脏疾病中的作用:炎症、纤维化与修复的协调者

Apoptotic Bodies in Kidney Disease: Orchestrators of Inflammation, Fibrosis, and Repair.
PubMed 文献 · J Am Soc Nephrol · 2026-03-03

本综述指出凋亡小体不仅是细胞碎片,更是细胞间通讯的动态介质。在健康肾脏中,凋亡小体被有效清除以维持稳态;在AKI中大量凋亡小体可放大炎症和内皮功能障碍,但有效清除时促进修复;在CKD中凋亡小体积累并携带促纤维化货物驱动纤维化,血管平滑肌细胞来源的凋亡小体还促进血管钙化。

要点

  • 凋亡小体是活跃的信号载体,而非惰性碎片。
  • AKI中凋亡小体负担加重炎症,但有效清除可促进修复。
  • CKD中凋亡小体积累通过其货物驱动纤维化和血管钙化。

核心结论

  • 凋亡小体是损伤、炎症、纤维化、再生和血管病理的主动调节者。

研究设计与样本

  • 综述,未报告系统检索范围。

主要发现

  • 健康肾脏中凋亡小体的有效胞葬维持组织稳态。
  • AKI中广泛肾小管上皮凋亡产生大量凋亡小体,清除受损时放大炎症、内皮功能障碍和适应性免疫激活。
  • CKD中持续低度凋亡合并胞葬缺陷导致凋亡小体在间质积累,其货物驱动成纤维细胞活化和纤维化。
  • 血管平滑肌细胞来源的凋亡小体作为钙磷晶体沉积的成核位点,促进CKD中膜性血管钙化。

临床怎么用

  • 调控胞葬、靶向凋亡小体衍生信号通路及工程化凋亡小体递送系统可能成为新的生物标志物和治疗策略。

局限性

  • 原文未报告系统检索范围,可能影响证据全面性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Apoptotic bodies are membrane-bound vesicles generated during the terminal stages of programmed cell death and are traditionally viewed as inert cellular debris. Emerging evidence, however, positions apoptotic bodies as dynamic mediators of intercellular communication with critical roles in kidney physiology and pathology. In the healthy kidney, efficient efferocytosis of apoptotic bodies maintains tissue homeostasis by ensuring immunologically silent clearance of apoptotic remnants. In AKI, extensive tubular epithelial apoptosis generates a high burden of apoptotic bodies that can amplify inflammation, endothelial dysfunction, and adaptive immune activation when clearance is impaired, yet promote resolution and epithelial repair when efficiently removed. In CKD, persistent low-grade apoptosis combined with defective efferocytosis leads to progressive accumulation of apoptotic bodies in the interstitium, where their bioactive cargo-including damage-associated molecular patterns, cytokines, growth factors, and profibrotic microRNAs-drives fibroblast activation, extracellular matrix expansion, and fibrosis. In the vasculature, apoptotic bodies derived from vascular smooth muscle cells act as nucleation sites for calcium-phosphate crystal deposition, linking apoptosis to the development of medial vascular calcification in CKD. Together, these findings highlight apoptotic bodies as active regulators of injury, inflammation, fibrosis, regeneration, and vascular pathology. Understanding the determinants of their pathogenic versus reparative effects could yield new biomarkers and therapeutic strategies, including modulation of efferocytosis, targeting apoptotic body-derived signaling pathways, and engineering apoptotic bodies-based delivery systems.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Cozzolino M, Ciceri P. Apoptotic Bodies in Kidney Disease: Orchestrators of Inflammation, Fibrosis, and Repair. J Am Soc Nephrol. 2026. PMID: 41774507. doi:10.1681/ASN.0000001073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。